论文部分内容阅读
目的探讨使用奥扎格雷钠治疗急性脑梗死的疗效。方法选取于2010年7月-2012年9月收治的110例急性脑梗死的患者,将其随机分为对照组和试验组各55例,对照组采用阿司匹林+血栓通+依达拉奉进行治疗;试验组在对照组基础上加用奥扎格雷钠进行治疗。观察2组患者的临床治疗疗效。结果试验组患者总有效率为90.91%明显高于对照组的76.36%,差异有统计学意义(P<0.05)。结论采用奥扎格雷钠治疗急性脑梗死具有较好的疗效,值得在临床推广使用。
Objective To investigate the efficacy of sodium ozagrel in the treatment of acute cerebral infarction. Methods A total of 110 patients with acute cerebral infarction who were admitted to our hospital from July 2010 to September 2012 were randomly divided into control group and experimental group with 55 cases in each. The control group was treated with aspirin plus Xueshuantong plus edaravone The experimental group was treated with ozagrel sodium on the basis of the control group. The clinical efficacy of the two groups was observed. Results The total effective rate was 90.91% in the experimental group was significantly higher than 76.36% in the control group, the difference was statistically significant (P <0.05). Conclusion Ozagrel sodium in the treatment of acute cerebral infarction has a good effect, it is worth to promote the use of the clinic.